Dendreon

Quick facts

Phase 2 pipeline

• APC8015F · Oncology
  APC8015F is a therapeutic cancer vaccine designed to stimulate an immune response against prostate cancer cells.
• Sipuleucel-T Injection
• Sipuleucel-T with Booster
• Sipuleucel-T without Booster

Phase 1 pipeline

• EC D-3263 HCl

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Dendreon portfolio CI brief
• Dendreon pipeline updates RSS